Company / R&D Expense
Cadre Holdings, Inc. R&D Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$11.4M
FY2025
5-year range
$5.6M / $11.4M
FY2021-FY2025
Trend
+36.0%
vs FY2024
Sector context
#103 of 110
Health Care
What the data says
Among 110 Health Care companies, Cadre Holdings, Inc. is in the bottom 6% for r&d expense. R&D Expense has increased for 4 consecutive years, from $6M in FY2021 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of +15.1%.
Improved from $7M to $11M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +20.8%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 110This company $11.4M Sector average $298.2M
▼
-96.2% below sector average
Key checks
Key Insights
- Cadre Holdings, Inc.'s r&d expense has grown for 4 consecutive years.
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, r&d expense increased 36.0% year-over-year.
- Ranks #103 out of 110 companies in the Health Care sector.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.4M | +36.0% |
| FY2024 | $8.4M | +20.5% |
| FY2023 | $7.0M | +7.6% |
| FY2022 | $6.5M | +14.7% |
| FY2021 | $5.6M | +0.0% |
| FY2020 | $5.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026